Diagnostic utility of plasma heparin-binding protein and procalcitonin among patients with bacterial infections: a single-center retrospective study
- 1Department of Clinical Laboratory, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230601 China
Abstract
Objective: This study aimed to evaluate the discriminatory capacity of plasma heparin-binding protein (HBP), procalcitonin (PCT), and composite immune inflammatory indices in differentiating bacterial infections from non-infection states, as well as to explore their potential for Gram classification and severity stratification.
Methods: A single-center retrospective case-control study enrolled 65 patients with confirmed bacterial infection and 135 non-infected controls. Plasma HBP, PCT, and complete blood count-derived indices were measured from initial blood samples collected within 24 hours of admission. Group comparisons were performed using statistical tests, and diagnostic performance of each biomarker was evaluated using receiver operating characteristic curves.
Results: HBP levels were significantly higher in infected patients than in controls (p < 0.001) and demonstrated the best discriminative performance among all markers (AUC = 0.86). Multivariable analysis identified HBP, monocyte, and lymphocyte count as independent predictors for Gram-positive infections, while HBP, PCT, and neutrophil count were associated with Gram-negative infections. Notably, HBP levels increased progressively from the non-infected group (19.45 ng/ml) to PCT-defined infection localized infection (35.13 ng/ml) and PCT-defined infection severe infection (111.95 ng/ml, p < 0.001), supporting its utility in PCT-defined severity stratification.
Conclusion: HBP is a promising biomarker for diagnosing bacterial infections, particularly Gram-negative infection, and for stratifying PCT-defined infection severity. However, given the exploratory nature of the Gram classification findings and the single-center retrospective design, these results require validation in larger prospective cohorts.
Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s12879-026-14089-6.
Related
- Comparative Analysis of Serum C-reactive Protein and Procalcitonin as Diagnostic Markers in Odontogenic Infections: A Cross-Sectional Study.
- Clinical utility of procalcitonin testing in critically Ill COVID-19 patients: a two-center retrospective cohort study
- Surveillance of bacterial and fungal infections in hospitalised COVID-19 patients: an ISARIC/WHO CCP-UK and UKHSA linkage study
- Omadacycline in the treatment of diverse bacterial infections: A retrospective analysis of clinical outcomes and adverse events
- Bloodstream Infections in Patients with Malignancy: Microbiological Epidemiology, Antimicrobial Resistance, and Factors Associated with Mortality in a Nine-Year Single-Center Retrospective Cohort
BibTeX
@article{wang2026diagnostic,
title = {{Diagnostic utility of plasma heparin-binding protein and procalcitonin among patients with bacterial infections: a single-center retrospective study}},
author = {Tao Wang and Yu Wei and Juan Chen and Hao Zhang and Jinjin Chen and Qiang Zhou},
journal = {BMC Infectious Diseases},
year = {2026},
month = aug,
doi = {10.1186/s12879-026-14089-6},
url = {https://doi.org/10.1186/s12879-026-14089-6},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Diagnostic utility of plasma heparin-binding protein and procalcitonin among patients with bacterial infections: a single-center retrospective study
AU - Tao Wang
AU - Yu Wei
AU - Juan Chen
AU - Hao Zhang
AU - Jinjin Chen
AU - Qiang Zhou
PY - 2026
DA - 2026/08/07
JO - BMC Infectious Diseases
DO - 10.1186/s12879-026-14089-6
UR - https://doi.org/10.1186/s12879-026-14089-6
AB - Objective: This study aimed to evaluate the discriminatory capacity of plasma heparin-binding protein (HBP), procalcitonin (PCT), and composite immune inflammatory indices in differentiating bacterial infections from non-infection states, as well as to explore their potential for Gram classification and severity stratification. Methods: A single-center retrospective case-control study enrolled 65 patients with confirmed bacterial infection and 135 non-infected controls. Plasma HBP, PCT, and complete blood count-derived indices were measured from initial blood samples collected within 24 hours of admission. Group comparisons were performed using statistical tests, and diagnostic performance of each biomarker was evaluated using receiver operating characteristic curves. Results: HBP levels were significantly higher in infected patients than in controls (p < 0.001) and demonstrated the best discriminative performance among all markers (AUC = 0.86). Multivariable analysis identified HBP, monocyte, and lymphocyte count as independent predictors for Gram-positive infections, while HBP, PCT, and neutrophil count were associated with Gram-negative infections. Notably, HBP levels increased progressively from the non-infected group (19.45 ng/ml) to PCT-defined infection localized infection (35.13 ng/ml) and PCT-defined infection severe infection (111.95 ng/ml, p < 0.001), supporting its utility in PCT-defined severity stratification. Conclusion: HBP is a promising biomarker for diagnosing bacterial infections, particularly Gram-negative infection, and for stratifying PCT-defined infection severity. However, given the exploratory nature of the Gram classification findings and the single-center retrospective design, these results require validation in larger prospective cohorts. Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s12879-026-14089-6.
SN - 1471-2334
ER -